Special Issues

Special Issue Title: Gynecological Oncology Treatment: Recent Progress in Clinical Modalities

· Print Special Issue Flyer

· Deadline for manuscript submissions: 28 February 2022

Special Issue Editor

Guest Editor

      Osamu Hiraike MD, PhD

      Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan

Website E-Mail

Interests: Pathophysiology of the Human Reproduction and Ovary; Reproductive Endocrinology; Benign Gynecological Tumors; Minimally Invasive Gynecological Surgery and Endoscopy; Repair of Pelvic Floor; Breast Cancer; Endometrial Cancer

Kenbun Sone, PhD

Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan

Website E-Mail

Interests: Epigenetic Mechanism in Gynecologic Oncology

Special Issue Information

Dear Colleagues,

Gynecological cancer including uterine cervical cancer, endometrial cancer and ovarian cancer constitutes unique disease properties. Representative recent topics of uterine cervical cancer are real world evidence of human papilloma virus vaccine and application of minimally invasive surgery (MIS). Treatment for early-stage endometrial cancer is almost established using MIS, and laparoscopic surgery and robotic surgery exhibit pronounced development and establishment of safety of these surgeries are crucial for patients. Another focus on epidemiology of endometrial cancer is the presence of familial trait that include Lynch syndrome. Recent molecular and genetic analysis of ovarian cancer is remarkable, and adjuvant chemotherapy for ovarian cancer became completely different from those of ten years ago. Artificial intelligence (AI) modalities might extend and expand human intelligence, and diagnostic significance of AI technology is steady progressing. Another remarkable issue related to gynecological cancer is the finding of gene fusions that are thought to be driver mutations. Oncology panel is developed and is supposed to be promising candidate modality to find the suitable drugs for unusual gynecologic tumors.
In this special issue, the authors will present novel and the most recent studies with regard to the development of gynecological cancers. These include the molecular characterization of gynecological cancers, treatment strategies of various gynecological cancers, application, ingenuity and limitation of MIS, and advances of diagnostic modalities (AI and oncology panel). 

Dr. Osamu Hiraike and Dr. Kenbun Sone

Guest Editors


Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. Submitted papers should be well formatted and use good English.


Cervical Cancer; Endometrial Cancer; Ovarian Cancer; Oncology Panel; Molecular Classification; Hereditary Gynecological Cancer; Minimally Invasive Therapy; Robotic Surgery; Hysteroscopy; Artificial Intelligence Technology

Share This Special Issue


Planned Paper(s)

Type: Review

Title:  Germline multigene panel testing in gynecological cancer

Author(s): Sayaka Ueno and Akira Hirasawa

Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 42, Issue 5